PharmaCyte Biotech Inc (PMCB) Stock Analysis

PharmaCyte Biotech Inc (PMCB) is a publicly traded company in the HEALTHCARE sector. It trades at $0.75, carries a market capitalization of $8.59M. This page summarizes the public market data, fundamentals, and frequently asked questions for PMCB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.75
• Market Cap: $8.59M
• EPS: $-0.89
• 52-Week High: $1.51
• 52-Week Low: $0.63

Market Sentiment

PharmaCyte Biotech Inc currently has a Neutral sentiment score of 0.05.

About PharmaCyte Biotech Inc

PharmaCyte Biotech Inc. (PMCB) is a clinical-stage biotechnology company headquartered in Laguna Hills, California, focused on developing cutting-edge cell therapies for cancer and diabetes. Utilizing its proprietary technology platform, the company aims to create transformative treatments that enhance patient outcomes and overall quality of life. With a strategic emphasis on advancing its clinical programs, PharmaCyte Biotech is well-positioned to make significant contributions to the rapidl...

GNG Research Analysis

GNG Research scores PharmaCyte Biotech Inc (PMCB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PMCB.

Frequently Asked Questions

Does PMCB pay dividends?

PharmaCyte Biotech Inc (PMCB) does not currently pay a regular dividend.

What is PMCB's market cap?

PharmaCyte Biotech Inc (PMCB) has a market capitalization of $8.59M with a current stock price of $0.75.